Echinococcosis, also known as hydatidosis or hydatid disease, is a parasitic zoonotic infection caused by the larval stages of tapeworms belonging to the genus Echinococcus. It is an important public health concern in many parts of the world, particularly in regions where livestock farming, animal husbandry, and close interactions between humans and domestic animals are common. The disease is transmitted from animals to humans and is characterized by the development of fluid-filled cysts or other parasitic lesions in various organs of the body, especially the liver and lungs.
The major species responsible for human echinococcosis include Echinococcus granulosus, which causes cystic echinococcosis (CE), and Echinococcus multilocularis, which causes alveolar echinococcosis (AE). Other less common species, such as Echinococcus vogeli and Echinococcus oligarthrus, are associated with polycystic echinococcosis. Among these forms, cystic and alveolar echinococcosis are the most clinically significant because of their potential to cause severe illness, long-term complications, and, in some cases, death.
The life cycle of Echinococcus species generally involves two types of hosts: definitive hosts and intermediate hosts. Dogs and other canids, such as wolves and foxes, serve as definitive hosts, where the adult tapeworms live in the small intestine and produce eggs that are released into the environment through faeces. Intermediate hosts, which commonly include sheep, goats, cattle, pigs, and other mammals, become infected by ingesting contaminated food, water, or pasture. Humans are accidental intermediate hosts and acquire the infection through the accidental ingestion of parasite eggs, often as a result of contaminated hands, food, water, or close contact with infected dogs.
Following ingestion, the eggs hatch in the intestine, releasing embryos that penetrate the intestinal wall and enter the bloodstream. They are subsequently transported to different organs, where they develop into larval cysts or tissue-invasive lesions, depending on the species involved. The liver is the most frequently affected organ, followed by the lungs, although the brain, bones, kidneys, and other tissues may also be involved. The disease often progresses slowly, and infected individuals may remain asymptomatic for several years before clinical manifestations become apparent.
The clinical presentation of echinococcosis depends largely on the location, size, and number of cysts, as well as the species of parasite responsible. Symptoms may include abdominal pain, nausea, coughing, chest discomfort, and difficulty breathing. In severe cases, cyst rupture may lead to allergic reactions, including anaphylaxis, while secondary infection and organ dysfunction may also occur. Echinococcosis is of considerable medical, veterinary, and socioeconomic importance because it affects both human health and livestock productivity.
Its prevention and control require a comprehensive One Health approach involving proper hygiene, regular deworming of dogs, safe disposal of infected animal organs, improved slaughterhouse practices, public health education, and effective veterinary surveillance. Early diagnosis and appropriate treatment are essential in reducing complications and improving patient outcomes. Therefore, understanding the epidemiology, life cycle, transmission, clinical features, diagnosis, treatment, and prevention of echinococcosis is fundamental to controlling this potentially serious zoonotic disease.
Biology and causative agents of Echinococcosis
Human echinococcosis (hydatidosis, or hydatid disease) is caused by the larval stages of cestodes (tapeworms) of the genus Echinococcus. Echinococcus granulosus (sensu lato) causes cystic echinococcosis and is the form most frequently encountered. Another species, E. multilocularis, causes alveolar echinococcosis, and is becoming increasingly more common. Two exclusively
New World species, E. vogeli and E. oligarthrus, are associated with โNeotropical echinococcosisโ; E. vogeli causes a polycystic form whereas E. oligarthrus causes the extremely rare unicystic form. Many genotypes of E. granulosus have been identified that differ in their distribution, host range, and some morphological features; these are often grouped into separate species in modern literature.
The known zoonotic genotypes within the E. granulosus sensu lato complex include the โclassicalโ E. granulosus sensu stricto (G1-G3 genotypes), E. ortleppi (G5), and the E. canadensis group (usually considered G6, G7, G8, and G10). Research on the epidemiology and diversity of these genotypes is ongoing, and no consensus has been reached on appropriate nomenclature thus far.
Types of Echinococcosis infection
Echinococcosis is a parasitic disease caused by infection with tiny tapeworms of the genus Echinocococcus. Echinococcosis is classified as either cystic echinococcosis or alveolar echinococcosis. The morphological appearance of the parasite is shown in Figure 1. Alveolar and cystic echinococcosis are emerging and reemerging in Europe, Africa, and Asia. The expansion of Echinococcus spp. tapeworms in wildlife host reservoirs appears to be driving this emergence in some areas.

Echinococcus spp. (family Taeniidae, class Cestoda) are zoonotic tapeworms currently infecting 2โ3 million persons worldwide and causing US $200-$800 million in annual economic losses related to human infection. The cestode Echinococcus multilocularis is the causative agent of alveolar echinococcosis, a rare but potentially lethal human disease.
Cystic echinocccosis (CE), also known as hydatid disease, is caused by infection with the larval stage of Echinococcus granulosus, a ~2-7 millimeter long tapeworm found in dogs (definitive host) and sheep, cattle, goats, and pigs (intermediate hosts). Although most infections in humans are asymptomatic, CE causes harmful, slowly enlarging cysts in the liver, lungs, and other organs that often grow unnoticed and neglected for years.
Alveolar echinococcosis (AE) disease is caused by infection with the larval stage of Echinococcus multilocularis, a ~1-4 millimeter long tapeworm found in foxes, coyotes, and dogs (definitive hosts). Small rodents are intermediate hosts for E. multilocularis. Although cases of AE in animals in endemic areas are relatively common, human cases are rare. AE poses a much greater health threat to people than CE, causing parasitic tumors that can form in the liver, lungs, brain, and other organs. If left untreated, AE can be fatal.
Neotropical Echinococcosis (Echinococcus Vogeli, E. Oligarthrus): The neotropical agents follow the same life cycle although with differences in hosts, morphology, and cyst structure. Adults of E. vogeli reach up to 5.6 mm long, and E. oligarthrus up to 2.9 mm. Cysts are generally similar to those found in cystic echinocccosis but are multi-chambered.
Hosts of Echinococcus Parasites
Echinococcus granulosus definitive hosts are wild and domestic canids. Natural intermediate hosts depend on genotype. Intermediate hosts for zoonotic species/genotypes are usually ungulates, including sheep and goats (E. granulosus sensu stricto), cattle (โE. ortleppiโ/G5), camels (โE. canadensisโ/G6), and cervids (โE. canadensisโ/G8, G10).
For E. multilocularis, foxes, particularly red foxes (Vulpes vulpes), are the primary definitive host species. Other canids including domestic dogs, wolves, and raccoon dogs (Nyctereutes procyonoides) are also competent definitive hosts. Many rodents can serve as intermediate hosts, but members of the subfamily Arvicolinae (voles, lemmings, and related rodents) are the most typical.
The natural definitive host of E. vogeli is the bush dog (Speothos venaticus), and possibly domestic dogs. Pacas (Cuniculus paca) and agoutis (Dasyprocta spp.) are known intermediate hosts. E. oligarthrus uses wild neotropical felids (e.g. ocelots, puma, jaguarundi) as definitive hosts, and a broader variety of rodents and lagomorphs as intermediate hosts.
Geographic distribution of Echinococcus parasites
Echinococcus granulosus sensu lato occurs practically worldwide, and more frequently in rural, grazing areas where dogs ingest organs from infected animals. The geographic distribution of individual E. granulosus genotypes is variable and an area of ongoing research. The lack of accurate case reporting and genotyping currently prevents any precise mapping of the true epidemiologic picture. However, genotypes G1 and G3 (associated with sheep) are the most commonly reported at present and broadly distributed.
In North America, Echinococcus granulosus is rarely reported in Canada and Alaska, and a few human cases have also been reported in Arizona and New Mexico in sheep-raising areas. In the United States, most infections are diagnosed in immigrants from counties where cystic echinococcosis is endemic. Some genotypes designated โE. canadensisโ occur broadly across Eurasia, the Middle East, Africa, North and South America (G6, G7) while some others seem to have a northern holarctic distribution (G8, G10).
E. multilocularis occurs in the northern hemisphere, including central and northern Europe, Central Asia, northern Russia, northern Japan, north-central United States, northwestern Alaska, and northwestern Canada. In North America, Echinococcus multilocularis is found primarily in the north-central region as well as Alaska and Canada. Rare human cases have been reported in Alaska, the province of Manitoba, and Minnesota. Only a single autochthonous case in the United States (Minnesota) has been confirmed. E. vogeli and E. oligarthrus occur in Central and South America.
Clinical presentation (signs and symptoms) of Echinococcus parasites
Echinococcus granulosus infections often remain asymptomatic for years before the cysts grow large enough to cause symptoms in the affected organs. The rate at which symptoms appear typically depends on the location of the cyst. Hepatic and pulmonary signs/symptoms are the most common clinical manifestations, as these are the most common sites for cysts to develop. In addition to the liver and lungs, other organs (spleen, kidneys, heart, bone, and central nervous system, including the brain and eyes) can also be involved, with resulting symptoms.
Rupture of the cysts can produce a host reaction manifesting as fever, urticaria, eosinophilia, and potentially anaphylactic shock; rupture of the cyst may also lead to cyst dissemination. Echinococcus multilocularis affects the liver as a slow growing, destructive tumor, often with abdominal pain and biliary obstruction being the only manifestations evident in early infection. This may be misdiagnosed as liver cancer. Rarely, metastatic lesions into the lungs, spleen, and brain occur.
Untreated infections have a high fatality rate. Echinococcus vogeli affects mainly the liver, where it acts as a slow growing tumor; secondary cystic development is common. Too few cases of E. oligarthrus have been reported for characterization of its clinical presentation.
Pathogenesis of Echinocococcus infection / disease
The pathogenesis of echinococcosis refers to the processes through which the larval stages of Echinococcus species enter the human body, develop within different organs, and cause tissue damage and clinical manifestations. The severity and progression of the disease depend on several factors, including the species of parasite involved, the location and size of the parasitic lesions, the growth rate of the cysts, and the immune response of the infected individual. The two major forms of human echinococcosis, CE and AE, differ considerably in their pathological development and clinical outcomes.
In cystic echinococcosis, which is primarily caused by the larval stage of Echinococcus granulosus, infection begins when humans accidentally ingest parasite eggs through contaminated food, water, soil, or hands. Following ingestion, the eggs hatch in the small intestine, releasing embryos known as oncospheres. These oncospheres penetrate the intestinal wall and enter the bloodstream, through which they are transported to various organs. The liver is the most commonly affected organ because it acts as the first major filtration site for blood returning from the intestines. The lungs are the second most frequently affected organs, although the parasites may occasionally reach the spleen, kidneys, heart, bones, and central nervous system, including the brain and eyes.
Once the oncospheres reach their destination, they develop into fluid-filled hydatid cysts surrounded by host-derived fibrous tissue (Figure 2). These cysts consist of an outer laminated layer and an inner germinal layer, which produces brood capsules and protoscolices, the developing larval forms of the parasite. The cysts generally grow slowly over several years and may remain undetected for a long period. Consequently, individuals with cystic echinococcosis are often asymptomatic during the early stages of infection.
Clinical manifestations usually develop when the enlarging cysts exert pressure on surrounding tissues and organs, interfere with their normal functions, or cause inflammation. Depending on the location and size of the cyst, affected individuals may experience abdominal pain, nausea, vomiting, hepatomegaly, coughing, chest discomfort, and difficulty breathing. Cysts located in the brain, bones, or other vital organs may produce more serious complications.
A particularly dangerous complication of cystic echinococcosis is cyst rupture, which may occur spontaneously or following physical trauma, surgery, or other mechanical injury. Rupture releases hydatid fluid and parasitic antigens into surrounding tissues or body cavities, potentially triggering severe allergic reactions, including anaphylactic shock, which can be life-threatening. Furthermore, the release of viable protoscolices may result in secondary echinococcosis, characterized by the development of additional cysts in other parts of the body.

In contrast, alveolar echinococcosis is primarily caused by Echinococcus multilocularis and is characterized by an infiltrative, tumour-like pattern of growth. Following ingestion of the parasite eggs, the oncospheres penetrate the intestinal wall and are transported mainly to the liver, where the larval stage develops into numerous small vesicles rather than a single, well-defined hydatid cyst.
These vesicles multiply through exogenous budding, progressively infiltrating and destroying the surrounding tissues. Unlike cystic echinococcosis, alveolar echinococcosis does not usually form a clearly encapsulated lesion, making it more aggressive and difficult to treat. The liver is the principal organ affected by alveolar echinococcosis, although the disease may spread to adjacent structures and, through the bloodstream, to distant organs such as the lungs and brain (Figure 3).
The progressive destruction of liver tissue and obstruction of bile ducts and blood vessels may lead to jaundice, abdominal pain, weight loss, fatigue, malaise, and impaired liver function. In advanced cases, extensive hepatic damage may result in liver failure and death. The disease may also remain undiagnosed for several years because of its slow initial progression and the nonspecific nature of its early symptoms.

Alveolar echinococcosis is considered one of the most severe forms of parasitic zoonotic disease because of its invasive nature, potential for metastasis-like spread, and high mortality when left untreated. Historically, reported mortality among untreated or inadequately treated patients has been substantial, with estimates ranging from 50% to 75% within approximately 10-15 years after diagnosis in some studies.
However, early detection, appropriate surgical intervention, and prolonged antiparasitic treatment with benzimidazole drugs, particularly albendazole, have significantly improved survival outcomes. The pathogenesis of echinococcosis demonstrates how the larval stages of Echinococcus species can cause progressive organ damage through cyst formation, tissue compression, and invasive growth. Understanding these pathological processes is essential for early diagnosis, effective treatment, prevention of complications, and improved management of affected individuals.
Diagnosis of echinococcosis infection
The diagnosis of echinococcosis involves a combination of clinical assessment, patient history, imaging techniques, and laboratory investigations. Early and accurate diagnosis is essential for identifying the infection, determining the extent of organ involvement, distinguishing between different forms of the disease, and selecting the most appropriate treatment. The diagnostic approach largely depends on the species of Echinococcus responsible for the infection, the affected organ, and the stage of disease progression.
A history of exposure to dogs, particularly sheepdogs, or other definitive hosts in regions where Echinococcus granulosus is endemic may raise suspicion of cystic echinococcosis. Patients may present with cyst-like masses in the liver, lungs, or other organs, although many infected individuals remain asymptomatic for several years. Clinical examination alone is usually insufficient to establish a definitive diagnosis; therefore, imaging and serological investigations are essential.
Imaging techniques: Medical imaging is the primary diagnostic method for detecting and evaluating cystic echinococcosis. Ultrasonography (US) is particularly useful for identifying hydatid cysts in the liver and is often the first-line imaging technique. It can reveal characteristic features such as cyst walls, internal septations, daughter cysts, and detached membranes. These findings help determine the stage and structural characteristics of the cyst.
Computed tomography (CT) scans provide detailed images of affected organs and are useful for identifying cysts in the lungs, abdomen, and other anatomical locations. Magnetic resonance imaging (MRI) is also valuable, particularly when assessing complex cysts, brain involvement, or the relationship between lesions and surrounding tissues.
Serological tests: Serological investigations are used to support and confirm the diagnosis of echinococcosis. These tests detect specific antibodies produced by the immune system in response to Echinococcus infection. Common methods include enzyme-linked immunosorbent assay (ELISA), indirect haemagglutination tests, and immunoblotting (Western blot). However, the sensitivity of these tests varies depending on the location, size, and stage of the cyst. A negative serological result does not necessarily exclude the infection.
Diagnosis of alveolar echinococcosis: AE, caused by E. multilocularis, is often diagnosed in adults, particularly individuals with a history of exposure to foxes, dogs, or contaminated environments in endemic regions. CT and MRI are important for detecting irregular, infiltrative lesions, which commonly affect the liver and may resemble malignant tumours. Serological tests are also used to identify antibodies against the parasite and support the diagnosis.
Additional investigations: Blood tests, including liver function tests, may help assess organ damage and complications. In selected cases, histopathological examination or molecular techniques such as polymerase chain reaction (PCR) may be used to support diagnosis. However, biopsy and cyst aspiration must be approached cautiously because of the risk of cyst leakage, dissemination, and severe allergic reactions.
The diagnosis of echinococcosis relies primarily on characteristic imaging findings supported by serological and, where necessary, additional laboratory investigations. Combining these diagnostic methods improves accuracy, facilitates early detection, and helps guide appropriate clinical management.
Epidemiology and risk factors of Echinocococcus infection
Echinococcosis is a zoonotic parasitic disease with a worldwide distribution, although its prevalence varies considerably across geographical regions, depending on environmental conditions, animal husbandry practices, socioeconomic factors, and the interaction between humans and infected animals. The two major forms of human echinococcosis are CE, caused by the larval stage of E. granulosus sensu lato, and AE, caused by E. multilocularis. Both forms are associated with distinct transmission cycles, geographical distributions, and epidemiological characteristics.
Cystic echinococcosis occurs predominantly in Africa, Europe, Asia, the Middle East, and Central and South America, with occasional cases reported in North America. Its distribution is closely associated with areas where sheep and other livestock are raised alongside domestic dogs. The transmission cycle typically involves dogs as definitive hosts and sheep, goats, cattle, pigs, and other livestock as intermediate hosts. Dogs become infected when they consume raw or inadequately cooked organs, particularly the liver and lungs, containing viable hydatid cysts from infected livestock. Within the dog’s small intestine, the larval stages develop into adult tapeworms, which produce eggs that are subsequently released into the environment through faeces.
Livestock acquire infection by ingesting parasite eggs from contaminated pasture, soil, feed, or water. Following ingestion, the eggs hatch in the intestine, and the released embryos migrate through the bloodstream to internal organs, where they develop into hydatid cysts. Humans become accidental intermediate hosts through the ingestion of eggs present in contaminated food, water, soil, or on unwashed hands following contact with infected dogs. The eggs can remain viable in favourable environmental conditions for several months, potentially increasing the risk of transmission.
Alveolar echinococcosis is caused by the larval stage of Echinococcus multilocularis and is particularly prevalent in the northern regions of Europe, Asia, and North America. Its natural transmission cycle primarily involves foxes, coyotes, and other wild canids as definitive hosts, while small mammals, especially rodents, serve as intermediate hosts. Domestic dogs and, less commonly, cats may also participate in the transmission cycle. Humans acquire infection accidentally through the ingestion of eggs contaminating food, water, soil, or other environmental materials.
Several risk factors contribute to the transmission of Echinococcus infection. These include poor personal hygiene, inadequate handwashing, consumption of contaminated food and water, close contact with infected dogs, home slaughter of livestock, improper disposal of infected animal organs, and allowing dogs to feed on raw offal. Occupational exposure among farmers, shepherds, veterinarians, and slaughterhouse workers may also increase the likelihood of infection.
Poor sanitation, inadequate veterinary services, limited public health awareness, and insufficient control of stray dog populations contribute to the persistence and spread of the parasite. Therefore, understanding the epidemiological patterns and associated risk factors is essential for developing effective prevention and control strategies against human and animal echinococcosis.
Treatment of Echinocococcus infection
The treatment of echinococcosis depends on several factors, including the type of Echinococcus species involved, the location, size, and stage of the cyst, the presence or absence of symptoms, and the general health condition of the affected individual. The two major forms of the disease, CE and AE, require different therapeutic approaches because of their distinct biological characteristics and patterns of progression.
Historically, surgery was considered the primary and most widely used treatment for cystic echinococcosis. Surgical intervention involves the removal of the hydatid cyst while minimizing the risk of rupture, spillage of cyst contents, and subsequent dissemination of the parasite. When performed appropriately, surgery can provide effective treatment, particularly in patients with large, complicated, or strategically located cysts. However, it may be associated with complications such as bleeding, infection, recurrence, and damage to surrounding tissues.
With advances in medical science, several alternative treatment methods have been developed, including antiparasitic chemotherapy, percutaneous cyst drainage, and the PAIR technique (Puncture, Aspiration, Injection, and Re-aspiration). Chemotherapy commonly involves the administration of benzimidazole drugs, particularly albendazole, which acts against the parasitic larvae and helps prevent further growth or recurrence of the cyst. Mebendazole may also be used in selected cases. These medications can be administered alone or in combination with other treatment methods, depending on the patient’s clinical condition and cyst characteristics.
The PAIR technique is a minimally invasive procedure that involves puncturing the cyst under imaging guidance, aspirating its fluid contents, injecting a scolicidal agent to destroy the parasite, and subsequently re-aspirating the cyst contents. This approach is particularly useful for selected uncomplicated cysts and may offer an alternative to conventional surgery. Nevertheless, it must be performed by experienced specialists because of the potential risks of allergic reactions, cyst leakage, and secondary infection.
Not all cystic echinococcal cysts require immediate treatment. Some cysts remain inactive, do not produce clinical symptoms, and may gradually resolve without medical or surgical intervention. In such cases, a management approach known as watch-and-wait or active surveillance may be adopted. This involves regular clinical and imaging examinations to monitor changes in cyst size, structure, and activity.
In contrast, the treatment of alveolar echinococcosis is considerably more challenging because the parasite grows infiltratively, resembling a malignant tumour, and can progressively damage affected organs. Complete surgical removal of the parasitic lesion, where feasible, is the preferred treatment and is usually followed by long-term albendazole therapy. For patients in whom complete surgical removal is impossible, prolonged or sometimes lifelong antiparasitic chemotherapy is generally required.
Prevention and control of Echinocococcus infection
The prevention and control of Echinococcus infection, also known as echinococcosis or hydatid disease, primarily involve interrupting the parasite’s life cycle and reducing contact between humans, domestic animals, and infected wildlife. Effective control measures require proper hygiene, responsible animal management, veterinary interventions, food safety practices, and public health education.
Prevention strategies differ slightly between cystic echinococcosis and alveolar echinococcosis because of their different transmission patterns. Effective prevention and control of echinococcosis depend on an integrated One Health approach involving humans, animals, and the environment.
Regular veterinary surveillance, public health education, responsible animal management, and improved sanitation are essential for reducing transmission and protecting both human and animal health.
Cystic Echinococcosis
Cystic echinococcosis is mainly associated with the transmission of Echinococcus granulosus between dogs and livestock, particularly sheep. The following measures help prevent infection:
- Prevent dogs from feeding on the raw organs or carcasses of infected sheep and other livestock, as these may contain viable hydatid cysts.
- Ensure the proper disposal of infected animal organs and carcasses through safe incineration, burial, or other approved methods.
- Control stray dog populations and ensure that domestic dogs receive regular veterinary care and appropriate deworming treatment.
- Restrict uncontrolled home slaughter of sheep and other livestock, and promote proper meat inspection in slaughterhouses.
- Prevent dogs from accessing slaughterhouse waste, livestock carcasses, and other potentially infected animal remains.
- Avoid consuming food or drinking water that may have been contaminated with dog faeces.
- Wash hands thoroughly with soap and clean water after handling dogs, their faeces, or contaminated materials, and always before preparing or eating food.
- Educate livestock farmers, animal handlers, and children about the routes of transmission and the importance of personal hygiene.
Alveolar Echinococcosis
Alveolar echinococcosis is primarily associated with Echinococcus multilocularis, which circulates between wild canids, such as foxes and coyotes, and small rodents. Preventive measures include:
- Avoid direct contact with wild animals, particularly foxes, coyotes, and stray dogs, as well as their faeces.
- Prevent domestic dogs and cats from hunting, consuming, or feeding on rodents and other potentially infected wild animals.
- Regularly deworm dogs and cats that may be exposed to wildlife, following veterinary recommendations.
- Avoid encouraging wild animals to approach residential areas or keeping wild animals as pets.
- Wash hands thoroughly with soap and clean water after handling domestic animals, particularly dogs and cats, and before handling food.
- Wash wild berries, vegetables, and other edible plants thoroughly before consumption, especially when collected from areas potentially contaminated by wild animal faeces.
- Teach children appropriate hygiene practices and discourage them from handling wild animals or their droppings.
References
Chiodini P.L., Moody A.H., Manser D.W (2001). Atlas of medical helminthology and protozoology. 4th ed. Edinburgh: Churchill Livingstone.
Ghosh S (2013). Panikerโs Textbook of Medical Parasitology. Seventh edition. Jaypee Brothers Medical Publishers,
Gillespie S.H and Pearson R.D (2001). Principles and Practice of Clinical Parasitology. John Wiley and Sons Ltd. West Sussex, England.
Gutierrez Y (2000). Diagnostic pathology of parasitic infections with clinical correlations. 2nd ed. New York: Oxford University Press.
Mandell G.L., Bennett J.E and Dolin R (2000). Principles and practice of infectious diseases, 5th edition. New York: Churchill Livingstone.
Roberts L, Janovy J (Jr) and Nadler S (2012). Foundations of Parasitology. Ninth edition. McGraw-Hill Publishers, USA.
Schneider M.J (2011). Introduction to Public Health. Third edition. Jones and Bartlett Publishers, Sudbury, Massachusetts, USA.
Discover more from Microbiology Class
Subscribe to get the latest posts sent to your email.
